Therapy News and Research

RSS

Discovery of combination protein leads to first-in-human clinical trial for leukemia

The discovery of tri-specific natural killer engagers (TriKE™), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially, has led to a new Phase I, first-in-human study to treat leukemia.

20 Sep 2019

Knowing when and how to taper off opioid dosage crucial to safe pain management

Many healthcare providers today try to avoid administering or prescribing opioid pain medications when possible because of the narcotics' addictive properties. But for some patients, opioid medications remain the most effective, most appropriate treatment for their subjective pain complaints.

20 Sep 2019

Researchers develop new technology to study cell nanomechanics

Researchers at Singapore-MIT Alliance for Research and Technology and MIT's Laser Biomedical Research Center have developed a new way to study cells, paving the way for a better understanding of how cancers spread and become killers.

20 Sep 2019

Whole-brain radiotherapy recommended for patients with brain metastases

Patients with brain metastases who received whole-brain radiotherapy that avoided memory-specific hippocampal neural stem cells experienced preserved cognitive function and reported fewer neurologic symptoms and better cognition over time, according to results from an NRG Oncology clinical trial presented Sept. 15, 2019 at the American Society for Radiation Oncology Annual Meeting in Chicago.

20 Sep 2019

Mitochondrial fission factor could represent a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.

20 Sep 2019

People with persistent back pain, headaches twice as likely to suffer from both disorders

People with persistent back pain or persistent headaches are twice as likely to suffer from both disorders, a new study from the University of Warwick has revealed.

20 Sep 2019

Anti-cancer protein promotes tumor resistance, shows study

Areas of solid tumors that have limited access to oxygen, a condition called hypoxia, are highly resilient against chemo and radiation therapy.

20 Sep 2019

BUSM researchers develop advanced protocol to improve gene therapy tool production

A method to create a faster and lower cost alternative for a gene therapy tool has been developed by Boston University School of Medicine researchers.

19 Sep 2019

Early palliative care linked to better survival in patients with advanced lung cancer

Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health Care System and Oregon Health and Science University researchers.

19 Sep 2019

Diabetes drug can also be used to treat heart failure

Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.

19 Sep 2019

New uses for CBD in genetic brain disorder

A new study has revealed that cannabidiol can help people with a rare brain condition called Angelman syndrome to improve their behavioral traits and to control seizures.

19 Sep 2019

Getting new therapy to patients can be harder than putting a lander on Mars

Getting new medical treatments from the lab benchtop to patients' bedsides can be harder and more expensive than putting a lander on Mars. But it doesn't have to be, says Tiffany Wilson, who heads a nonprofit organization that guides new medical solutions from the lab bench to the bedside.

19 Sep 2019

The resurgence of gene therapy pioneer

Twenty years ago, scientists and investors were giddy over the promise of gene therapy to cure a host of deadly diseases. But the tragic death of a young man from an experimental treatment in 1999 nearly ended a scientist's career and the entire field.

19 Sep 2019

Penn State physician highlights the importance of speaking frankly about suicide

Suicide can be difficult to talk about due to the cultural stigma surrounding it and the devastating and lasting impact it has on people, families and communities. But it's important to do so.

19 Sep 2019

Doctors and nurses with addictions often denied a crucial recovery option

Dr. Wesley Boyd, an associate professor of psychiatry at Harvard, has spent years working with state programs that help doctors, nurses and other health care workers who have become addicted to opioids get back on their feet professionally.

19 Sep 2019

All-in-one pill reduces estimated risk of cardiovascular disease, study shows

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25% in a study published today in the New England Journal of Medicine.

19 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

19 Sep 2019

Early combination therapy provides long-term benefits for patients with type 2 diabetes

A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.

19 Sep 2019

NMDAR receptor is responsible for breast-to-brain metastases, shows study

In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.

19 Sep 2019

Therapy News and Research

Discovery of combination protein leads to first-in-human clinical trial for leukemia

Knowing when and how to taper off opioid dosage crucial to safe pain management

Researchers develop new technology to study cell nanomechanics

Whole-brain radiotherapy recommended for patients with brain metastases

Mitochondrial fission factor could represent a promising target for cancer therapy

People with persistent back pain, headaches twice as likely to suffer from both disorders

Anti-cancer protein promotes tumor resistance, shows study

BUSM researchers develop advanced protocol to improve gene therapy tool production

Early palliative care linked to better survival in patients with advanced lung cancer

Diabetes drug can also be used to treat heart failure

New uses for CBD in genetic brain disorder

Getting new therapy to patients can be harder than putting a lander on Mars

The resurgence of gene therapy pioneer

Penn State physician highlights the importance of speaking frankly about suicide

Doctors and nurses with addictions often denied a crucial recovery option

All-in-one pill reduces estimated risk of cardiovascular disease, study shows

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

Early combination therapy provides long-term benefits for patients with type 2 diabetes

NMDAR receptor is responsible for breast-to-brain metastases, shows study

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News